Nigel G J Richards Selected Research

Leukemia

10/2012	A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells.
4/2008	Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients.
12/2006	An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nigel G J Richards Research Topics

Disease

4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 08/2005
3	Neoplasms (Cancer) 05/2022 - 01/2019
3	Leukemia 10/2012 - 12/2006
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Feeding and Eating Disorders (Eating Disorder) 01/2005
1	Hyperoxaluria (Oxaluria) 01/2005
1	Obesity 01/2005

Drug/Important Bio-Agent (IBA)

6	Asparaginase (Elspar)FDA Link 01/2020 - 08/2005
5	AsparagineIBA 01/2020 - 01/2006
5	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 01/2019 - 08/2005
3	EnzymesIBA 01/2020 - 01/2005
1	Adenosine Triphosphate (ATP)IBA 05/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2022
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 05/2022
1	Proteins (Proteins, Gene)FDA Link 04/2008
1	Agouti-Related ProteinIBA 01/2005
1	OxalatesIBA 01/2005
1	Peptides (Polypeptides)IBA 01/2005
1	PeptoidsIBA 01/2005
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 01/2005

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 01/2020